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Objectives: The reported rate of abdominal aortic graft infections (AGIs) is low, but its incidence and associated factors
have not been evaluated on a population level. We hypothesized that AGI occurs more often in patients with
periprocedural nosocomial infections and less often after endovascular aneurysm repair (EVAR).
Methods: A retrospective cohort study was done of all patients undergoing abdominal aortic aneurysm (AAA) repair
(1987-2005) in Washington State by using the Comprehensive Hospital Abstract Reporting System (CHARS) data.
Nosocomial infection was defined as one or more of pneumonia, urinary tract infections, blood stream septicemia, or
surgical site infection at the index admission. Readmissions and reintervention for graft infections defined AGIs
excluding the diagnostic code of renal failure or those who appeared to have dialysis grafts.
Results: Between 1987 and 2005, 13,902 patients (mean age, 71.3  8.8 years; 90.8% men) underwent AAA repair
(12,626 open, 1276 EVAR). The cumulative rate of AGIs in the cohort was 0.44%. The 2-year rate of AGI was 0.19%
among open vs 0.16% in EVAR (P .75) and 0.2% in both elective and nonelective patients. Open procedures had greater
rates of perioperative pneumonia (11.1% vs 2.4%, P < .001), blood stream septicemia (1.6% vs 0.7%, P < .01), and
surgical site infection (.5% vs 0%, P< .012) compared with EVAR. When individually analyzed, blood stream septicemia
(.93% vs 18%, P .014) and surgical site infection (1.61% vs 0.19%, P .01) were significantly associated with AGIs. The
median time to AGI was 3.0 years, and AGI presented sooner (<1.4 years) if nosocomial infection occurred at the index
admission. This risk of developing AGI after open repair was highest in the first postoperative year (32% of all AGI
occurred in year 1). In an adjusted model, blood stream septicemia was significantly associated with AGI (odds ratio, 4.2;
95% confidence interval, 1.5-11.8)
Conclusions: The incidence of AGI was low, presented most commonly in the first postoperative year, and was similar
among patients undergoing open AAA repair and EAVR. Patients with nosocomial infection had an earlier onset of AGI.
The 2-year rate of AGI was significantly higher in patients who had blood stream septicemia and surgical site infection in
the periprocedural hospitalization. These data may be helpful in directing surveillance programs for AIG. (J Vasc Surg
2008;47:264-9.)The incidence of prosthetic aortic graft infections
(AGI) has been reported to range between 0.6% and 3%.1-3
Aortic graft infection is a serious and life-threatening con-
dition with a mortality rate of 20% to 40%, an amputation
rate as high as 11%, and a reinfection rate of approximately
18%.4-6 Factors associated with AGI are not clearly under-
stood and require further delineation. Understanding pre-
dictive factors may be important in developing surveillance
programs for AGI.
Most studies of AGI are single-center evaluations with
small numbers of patients and incomplete data on patient
characteristics.4,7-9 The use of a population-level database
may help define the incidence of AGI, evaluate trends over
time, and identify the factors contributing to AGI. Aortic
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264graft infection may be caused by contamination during
surgery or infectious processes after surgery, or both, but
this has yet to be determined. We hypothesized that AGI is
associated with nosocomial infections that occur during the
initial hospitalization. We also hypothesized that AGI oc-
curs less frequently with endovascular repair (EVAR) and
more commonly with emergency repair.
METHODS
Study design. A retrospective cohort study was con-
ducted using a statewide hospital administrative discharge
database. Records of inpatient hospitalizations between
1987 and 2005 were evaluated to assess the incidence of
aortic graft infections.
Data source. Data were obtained from the Washing-
ton State Comprehensive Hospital Abstract Reporting Sys-
tem (CHARS). This data set is derived from all public and
private hospitals in the state, excluding Veterans Affairs and
United States military hospitals excluded. It contains de-
mographic variables, admission and discharge administra-
tive details, payer status, International Classification of
Diseases, Ninth Revision (ICD-9) procedure and diagnosis
codes, and hospital identifiers. CHARS also allows for
tracking of subsequent hospitalizations and linkage to vital
statistics records. The data are maintained by the Washing-
ton State Department of Health, Office of Hospital and
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currently collected using the Uniform Billing (UB) 92
format (previously, UB82). The CHARS system is de-
signed to accommodate data elements from the Medicare
provider-billing file. The reporting is done by the hospitals
on the basis of information in the patient charts. The
CHARS data are entered by hospital coders according to
information in the charts. This study was granted an excep-
tion by agreement of the University of WashingtonHuman
Subject Review Committee and the Washington State De-
partment of Health. The data set includes only anonymous
data and is considered within the public domain.
Subjects. CHARS records from 1987 to 2005 were
searched to identify all cases of abdominal aortic surgery
indicated by the ICD-9 procedure. Cases included in the
cohort were patients aged 18 years who had the ICD-9
code for abdominal aortic surgical procedures. Patients
were categorized by ICD-9 diagnosis codes for repair of the
abdominal aortic aneurysm from procedure codes as repairs
with open and endovascular techniques. Classification as
elective vs nonelective (which included “urgent” and
“emergency”) was based on the CHARS variable for ad-
mission type. For this study, any cases that were defined as
urgent were placed into the nonelective category.
Variable definitions. Nosocomial infection (NI) was
defined as an infection occurring in a patient in a hospital or
other health care facility in whom it was not present or
incubating at the time of admission; or the residual of an
infection acquired during a previous admission. We evalu-
ated diagnostic codes for NI, which were postoperative
pneumonia (997.3, 482.x), urinary tract infections (599.0,
V13.02), blood stream septicemia (BSI; 038.x), and surgi-
cal site infection (SSI; 998.5, 998.51, 998.59), or a com-
bination of these, at the index admission.
To identify patients with AGI, code 996.62 was used to
all identify patients with many types of graft infection. This
code includes infection and inflammatory reaction as a
result of any internal prosthetic device, implant, or graft
due to a vascular implant. This code was then combined
with appropriate aortic resections associated with revision
of AGI codes, including 38.34, resection of vessel with
anastomosis abdominal aorta; 38.44, resection of vessel
with replacement abdominal aorta; 38.64, other excision of
vessels abdominal aorta.
All other patients were excluded, and our study cohort
reflects only patients undergoing aortic resection with an
associated code of infected graft at the same readmission.
To further assure that we did not overestimate, all patients
with the code for dialysis renal failure preoperative and
postoperatively were excluded (v56.0) to remove any pos-
sibility of dialysis graft infections in the cohort.
A modified version of the Charlson Comorbidity In-
dex10 was calculated for each patient. The Charlson mea-
sure, which has been adapted for use with administrative
claims, is a weighted index of comorbidity status based on
ICD-9 codes from inpatient records. Scores range from 0
to 3, where 0 indicates the absence of comorbid conditionsand a score 0 indicates the presence of one or more
comorbid conditions.
Classification as elective vs nonelective (which included
“urgent” and “emergency”) was based on the CHARS
variable for admission type. For this study, any cases that
were defined as urgent were placed into the nonelective
category.
Outcome metrics included in-hospital death, readmis-
sion, reintervention, and 30-day mortality. Readmissions
classified by the presence of diagnostic codes for vascular
graft infections combined with procedures associated with
treatment of an infected aortic graft (such as extra-anatomic
bypass or redo aortic surgery) were identified. In-hospital
death is directly coded as a discharge status for the index
admission. The 30-day mortality was defined as “all-cause”
death 30 days of discharge as ascertained from Washing-
ton State Vital Records.
Statistical analysis. Descriptive statistics were calcu-
lated for the entire cohort and subgroups. Categoric vari-
ables were compared using Pearson 2 statistic, and contin-
uous variables were evaluated using analysis of variance.
Logistic regression was used to create a 2-year model to
define risk of AIG. The adjusted model contains all covari-
ates and includes clustering by hospital. The cumulative
hazard of readmission with graft infection was estimated
using Nelson-Aalen methods. The Nelson-Aalen estimator
is a nonparametric estimator of the cumulative hazard
function based on a sample that is subject to right censor-
ing. The cumulative hazard is estimated by summing the
hazard of, in this case, graft infection over time. This
time-to-event analysis was used to account for the variable
follow-up time among subject in the cohort. Statistical
analysis was performed using Stata 9 statistical software
(Stata Corp, College Station, Tex).
As well, to account for the introduction of the code for
EVAR in 2000, the 2-year rates of infection were used
when open surgery was compared with EVAR. This was
done to insure that there was a fair comparison of the two
treatment methods and that the incidence of AGI was not
skewed by the large open experience reported in the data.
RESULTS
Demographic information. Between 1987 and 2005,
13,902 patients (mean age, 71.3  8.8 years; 90.8% men)
underwent abdominal aortic surgery; of these, 12,626 had
open repair and 1276 had EVAR (Table I). Patients under-
going EVAR had higher Charlson scores than those having
open aortic surgery (P  .001; Table II). A total of 9835 of
the cases in the study period were elective procedures
(70.8%).
Outcomes. The in-hospital mortality rate for the en-
tire cohort was 9.81%, with 2.35% for EVAR vs 10.6% for
open surgery (P  .001). The 30-day mortality was 3.8%
for elective aortic surgery vs 25.0% for nonelective aortic
surgery. The cumulative rate of AIG in the cohort was
0.44%. The in-hospital mortality rate at the first readmis-
sion for those identified with AGI was 18%, and the overall
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28%.
Group comparison. Patients undergoing aortic aneu-
rysm repair were compared evaluating elective or nonelective
Table I. Cohort characteristics
Total
Subjects, No. 13,902
Age, mean years 71.3
Male, % 79.3
Charlson Comorbidity Index category, %
0 1.9
1 58.3
2 32.1
3 7.7
Endovascular repair, % 9.2
Any nosocomial infection, % 13.1
Pneumonia 10.3
Urinary tract infection 1.6
Blood stream septicemia 1.6
Surgical site infection 0.4
Length of stay, mean days 9.1
Discharge status, %
Home 79.3
Care facility 10.9
In-hospital death 9.8
Readmission with graft infection, % 0.4
Graft infection 2 years 0.2
Days to graft infection, median 937
Graft infection rate/1000 person-years 0.7
Table II. Cohort characteristic by procedure type
Characteristic Open EVAR P
Subjects, No. 12,626 1276
Age, mean years 71.0 73.5 .001
Male, % 79.9 83.4 .001
Charlson Comorbidity Index
category, % .001
0 2 1.1
59.2 49.1
2 31.5 38.4
3 7.4 11.4
Elective admission, % 68.7 90.8 .001
Any nosocomial infection, % 14.0 4.0 .001
Pneumonia 11.1 2.4 .001
Urinary tract infection 1.7 1.2 .2
Blood stream septicemia 1.6 0.7 .01
Surgical site infection 0.5 0.0 .01
Length of stay, mean days 9.6 3.6
Discharge status, % .001
Home 78.1 90.7
Care facility 11.3 7.0
In-hospital death 10.6 2.3
Readmission with graft
infection, % 0.4 0.2 .3
Graft infection 2 years, % 0.2 0.2 .8
Days to graft infection, median 1100 684
Graft infection rate/1000
person-years 0.7 1.6 .07
EVAR, Endovascular aneurysm repair.repair (Table I), open and EVAR procedures (Table II), NIat the index visit (Table III), and by the development of
AGI (Table IV). Nonelective patients were more likely
male and significantly more likely to develop NIs (18.6 vs
10.8, P .001). Nonelective patients had longer lengths of
stay (11.7 vs 8.0, P  .001) and were less likely to be
discharged home (58.6% vs 87.8%, P  .001). The rate of
readmission with a graft infection and the 2-year rate of
Nonelective Elective P
4067 9835
71.7 71.1 .001
77.8 80.0 .003
.001
2.2 1.4
61.6 56.9
29.2 33.4
7.0 8.0
2.9 11.8 .001
18.6 10.8 .001
13.4 9.1 .001
2.8 1.2 .001
3.2 0.9 .001
0.8 0.3 .001
11.7 8.0 .001
.001
58.6 87.8
16.8 8.5
24.6 3.7
0.4 0.5 .6
0.2 0.2 .6
540 1330 .1
0.7 0.7 .5
Table III. Cohort characteristic by index nosocomial
infection
Characteristic
Nosocomial infection
PNo Yes
Subjects, No. 12,080 1822
Age, mean years 71.1 72.4 .001
Male, % 80 75.1 .001
Charlson Comorbidity Index
category, % .005
0 1.9 1.7
1 58.1 59.5
2 32 33.2
3 8 5.7
Elective admission, % 72.6 58.4 .001
Length of stay, mean days 8 16 .001
Discharge status, % .001
Home 81.8 62.7
Care facility 9.2 22.8
In-hospital Death 9.1 14.5
Readmission with graft
infection, % 0.4 0.6 .4
Graft infection 2 years 0.2 0.3 .2
Days to graft infection, median 1100 511.5 .3
Graft infection rate/1000
person-years 0.7 0.9 .2
CCI, Charlson Comorbidity Index.graft infection were similar (0.2% vs 0.2%, P  .6).
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more often younger, healthier, more likely to develop NIs,
and less likely to be discharged to home. Patients having
open repair and EVAR had similar 2-year rates of graft
infection and infection rates (0.2% vs 0.2%, P  .8). When
compared using 1000 person-years, however, the rate of
infection for EVARwas nearly half (0.7% vs 1.6%, P .07),
although this was not a significant difference. Patients who
had open aortic procedures had greater rates of pneumonia
(11.1% vs 2.4%, P  .001), BSI (1.6% vs 0.7%, P  .01),
and SSI (.5% vs 0%, P  .012) compared with EVAR.
Patients who developed NIs (Table III) at their index
visit were more likely to have longer index hospitalizations
(8 days vs 16 days, P  .001) and less likely to have had
elective surgery (72.6 vs 58.4, P  .001). Patients who
developed a NI at the index admission had shorter times to
developing AIG (511 vs 1100 days). Most (72.6%) of the
cases without development of NI were elective cases com-
pared with patients developing a NI, of which 58.4% were
elective (P  .001).
The 2-year rate of AGI was 0.19% among open vs
0.16% in EVAR (P  .75) and 0.2% in both elective and
nonelective patients. The 2-year rate of AGI was higher,
although not significant, after any index NI (0.33% vs
0.17%, P .16) or pneumonia (0.35% vs 0.18%, P .16).
Blood stream septicemia (0.93% vs 0.18%, P  .014) and
SSI (1.61% vs 0.19%, P .01) were significantly associated
with the development of AGI. The median time to AGI
presented earlier if a perioperative NI occurred (1100 vs
511, P .3). This risk of developing AGI after open repair
was highest in the first postoperative year, with 32% of all
graft infections in the open cohort presenting in year 1. Of
interest was that no 1-year AGI was seen in the EVAR
group. Odds ratios (ORs) for AGI within 2 years showed
that after adjustment, BSI was significantly associated with
Table IV. Cohort characteristic by graft infection
(readmission)
Characteristic
Aortic graft
infection
PNo Yes
Subjects, No. 13841 61
Male, % 79.3 82.0 .6
CCI category, % .008
0 1.9 6.6
1 58.3 59.0
2 32.1 34.4
3 7.8 0.0
Elective admission, % 70.7 73.8 .6
Endovascular repair, % 9.2 6.7 .5
Length of stay, mean days 9.1 11.5 .03
Discharge status, % .04
Home 79.2 88.5
Care facility 10.9 11.5
In-hospital death 9.9 0.0
CCI, Charlson Comorbidity Index.AGI (OR, 4.2; 95% confidence interval (CI), 1.5-11.8;Table V). The Fig demonstrates the difference in the cu-
mulative incidence of AGI in patients undergoing open
repair and EVAR (log-rank P  .34).
DISCUSSION
To our knowledge, this study is the first population-
level analysis of AGI. Most of the current published reports
are of case series with limited numbers whereas this study is
a population level analysis of AGI.2,11,12 Management of
AGI ranges from complete graft excision, to extra-ana-
tomic bypass, to in-line reconstruction using a variety of
conduits. The overall mortality rate from AGI is high, from
20% to 40%, and AGI carries many other complications,
including reinfection of graft material after surgery, chronic
septicemia, and major amputation.4,7,8,13-15
Little is known of the true incidence of AGI or contrib-
uting factors that may increase risk. This study demon-
strates that the rate of AGI is low, is significantly associated
with BSI and SSI, and has a 1-year mortality rate of 28%.
This low rate of infection and high mortality has been
similarly reported in previous small series.13,15,16 We found
no difference in the 2-year rate of AGI between patients
having open and EVAR repair. Aortic graft infection was
also similar between elective and nonelective procedures.
Most of the infections presented in the first postoperative
year in the open repair cohort, which is contrary to conven-
tional wisdom suggesting that AGI occurs at 3 to 5 years
after aortic surgery.17 This study also demonstrates that
AGI after EVAR is extremely rare18 and that the 2-year
rates of AGI were similar among patients undergoing open
repair and EVAR.
Improvement in the diagnosis of AGI as well as man-
agement schemes preventing AGI, such as use of rifampin
grafts,3,19-21 have been suggested. With the knowledge of
possible causes of AGI as well as the onset and time of an
aortic infection, it may be possible to prevent these graft
infections or intervene earlier in their course. Patients after
open aortic repair with known BSI or SSI infections may
benefit from surveillance in the first postoperative year
because this appears to represent the period of greatest risk
of infection. Possibilities include the more liberal use of
computed tomography in patients at high risk or longer
treatment of BSI infections with antibiotic therapy.
The finding that EVAR and open procedures had sim-
ilar rates of infection suggests that intraoperative contami-
nation may not be the only source of graft infection. It
would not be expected that EVAR, where the graft material
is not manipulated, would carry a similar rate of AGI. This
study supports the theory that periprocedural infection has
a significant role in the development of AGI. The role of
NIs, specifically BSI, suggests that there may be an inter-
mediate step of hematogenous seeding of aortic grafts in
the genesis of AGI.
This study has several limitations. The CHARS data-
base did not include patients in military hospitals, Veterans
Affairs medical centers, or Washington residents who un-
derwent aortic surgery in the state and immediately moved
to a different state. Because of the way the CHARS data-
scular
ital.
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grafts related to access for dialysis. All patients with the
diagnosis of dialysis and dialysis grafts were removed from
the study. This may have led to an under-representation of
graft infection because there is the possibility that patients
with AGIs may also incur renal failure as a postoperative
complication.
The potential for inclusion bias as a result of the limited
coding schemes for the many clinical entities that make up
vascular graft infection cannot be entirely excluded. Classi-
fication as elective vs nonelective, which included “urgent”
and “emergency,” was based on the CHARS variable for
admission type. For this study, any cases that were defined
as urgent were placed into the nonelective category. This
may be an over-representation and is a coding bias based on
the institutions submitting data. As well, the Charlson
Comorbidity Index is intended to adjust for comorbid
illnesses, it does not incorporate the degree of illness, nor
has it been specifically applied to the population of patients
undergoing aneurysm or infected graft repair. There is also
the possibility of a type II error because the occurrence of
AGI is so low in the population at large. Another limitation
of discharge data is that the ICD-9 codes are relatively
nonspecific for organisms and inconsistent in entry; there-
Table V. Odds ratios for graft infection 2 years
Covariates Unadjusted OR
EVAR index procedure 0.8
Age 65 1.1
CCI category (1) 0.5
Income above median 1.7
Elective admission 0.8
High-volume hospital 1.1
Any nosocomial infection 1.9
Pneumonia 2.0
Bloodstream septicemia 5.1
Surgical site infection 8.7
CCI, Charlson Comorbidity Index; CI, confidence interval; EVAR, endova
*The adjusted model contains all covariates and includes clustering by hosp
Fig. Nelson-Aalen cumulative hazard estimates. Graft infection
readmission by index nosocomial infection (NI).fore, no one organism was identified from discharge data.Finally, we used patient status as a Medicaid beneficiary or
uninsured as a proxy of socioeconomic status22,23 owing to
lack of more direct assessments.
CONCLUSION
We are suggesting a paradigm shift in the way AGI is
perceived. This study supports that AGI is significantly
associated with periprocedural infections and occurs most
commonly in the first year after surgery. The identification
of patients at highest risk may be lead to the creation of
preventive programs for high-risk patients to prevent future
aortic infection. Further studies that look at possible pre-
vention plans of AGI are warranted, although this will be
difficult due to the low incidence.
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